Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Easton Capital Investment Group
AddedFeb 13, 2024
UpdatedJun 28, 2026
Easton Capital Investment Group

Easton Capital Investment Group

Operating

Easton Capital Investment Group: A US-based venture capital firm specializing in healthcare industries.

Location
New York City, NY, US
Founded
1999
Firm
Compare
Portfolio
Employees

Investments

Welltrackone
Welltrackone

Total Raised

$3.2M

Rounds

4

Series Unknown$1.5MMay 2020
Series A$1.5MAugust 2015
Wildflower Health
Wildflower Health

Total Raised

$40.8M

Rounds

5

Series B$5MJune 2015
PerceptiMed
PerceptiMed

Total Raised

$11M

Rounds

4

Series A$5.4MMarch 2015
Series Unknown$3.1MDecember 2012
electroCore
electroCore
Public

Total Raised

$148.8M

Rounds

10

Series A$55MJune 2014
Medcpu
Medcpu

Total Raised

$53.9M

Rounds

6

Series B$9.3MMay 2014
Respiratory Motion
Respiratory Motion
Series D

Total Raised

$33.5M

Rounds

15

Series B$7.8MFebruary 2014
TigerConnect
TigerConnect

Total Raised

$448.9M

Rounds

8

Series B$23MJanuary 2014
Series A$11.4MFebruary 2012
Solx
Solx
Public

Total Raised

$9.1M

Rounds

4

Debt Financing$2.1MDecember 2013
Series Unknown$3.3MJanuary 2012
Precise Light Surgical
Precise Light Surgical

Total Raised

$9.1M

Rounds

2

Series Unknown$4.5MOctober 2013
Medikly
Medikly
Debt

Total Raised

$1.2M

Rounds

4

Series A$1.2MFebruary 2013
Within3
Within3
Private Equity

Total Raised

$120M

Rounds

3

Series B$20MDecember 2012
SeedNovember 2011
Resolve Therapeutics
Resolve Therapeutics

Total Raised

$8.9M

Rounds

3

Series B$5.8MNovember 2012
Series A$2MMay 2011
Achronix Semiconductor
Achronix Semiconductor

Total Raised

$135.8M

Rounds

5

Series Unknown$9.8MAugust 2012
Emkinetics
Emkinetics

Total Raised

$11M

Rounds

3

Series C$8MOctober 2011
Series B$2.8MMarch 2010
bluebird bio
bluebird bio
Public

Total Raised

$3.4B

Rounds

17

Series C$30MApril 2011
Series B$35MMarch 2010
Format Dynamics
Format Dynamics

Total Raised

$9.9M

Rounds

5

Series B$5.5MJune 2010
Cardiomems
Cardiomems
Public

Total Raised

$232.6M

Rounds

10

Series Unknown$37.9MMay 2010